关注
Maciej Salagierski
Maciej Salagierski
未知所在单位机构
在 g.elearn.uz.zgora.pl 的电子邮件经过验证
标题
引用次数
引用次数
年份
Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2: ERG gene fusion
M Salagierski, JA Schalken
The Journal of urology 187 (3), 795-801, 2012
1972012
Role of active surveillance for localized small renal masses
MC Mir, U Capitanio, R Bertolo, I Ouzaid, M Salagierski, M Kriegmair, ...
European urology oncology 1 (3), 177-187, 2018
972018
Differential expression of PCA3 and its overlapping PRUNE2 transcript in prostate cancer
M Salagierski, GW Verhaegh, SA Jannink, FP Smit, D Hessels, ...
The Prostate 70 (1), 70-78, 2010
632010
Early experience in reconstruction of long ureteral strictures with allogenic amniotic membrane
A Koziak, M Salagierski, A Marcheluk, R Szcześniewski, M Sosnowski
International journal of urology 14 (7), 607-610, 2007
602007
Suture techniques during laparoscopic and robot‐assisted partial nephrectomy: a systematic review and quantitative synthesis of peri‐operative outcomes
R Bertolo, R Campi, T Klatte, MC Kriegmair, MC Mir, I Ouzaid, ...
BJU international 123 (6), 923-946, 2019
562019
Prostate cancer liquid biopsy biomarkers’ clinical utility in diagnosis and prognosis
M Matuszczak, JA Schalken, M Salagierski
Cancers 13 (13), 3373, 2021
502021
Systematic review and pooled analysis of the impact of renorrhaphy techniques on renal functional outcome after partial nephrectomy
R Bertolo, R Campi, MC Mir, T Klatte, MC Kriegmair, M Salagierski, ...
European Urology Oncology 2 (5), 572-575, 2019
452019
The role of ablation and minimally invasive techniques in the management of small renal masses
M Salagierski, A Wojciechowska, K Zając, T Klatte, RH Thompson, ...
European Urology Oncology 1 (5), 395-402, 2018
402018
Systematic review of the management of local kidney cancer relapse
MC Kriegmair, R Bertolo, PI Karakiewicz, BC Leibovich, B Ljungberg, ...
European Urology Oncology 1 (6), 512-523, 2018
342018
Percutaneous ultrasound‐guided radiofrequency ablation for kidney tumors in patients with surgical risk
M Salagierski, M Salagierski, A SALAGIERSKA‐BARWIŃSKA, ...
International journal of urology 13 (11), 1375-1379, 2006
292006
A liquid biopsy in bladder Cancer—the current Landscape in urinary biomarkers
M Matuszczak, A Kiljańczyk, M Salagierski
International Journal of Molecular Sciences 23 (15), 8597, 2022
282022
Inflammation and benign prostatic hyperplasia: cause or consequence?
G Robert, M Salagierski, JA Schalken, A de La Taille
Progres en Urologie: Journal de L'association Francaise D'urologie et de la …, 2010
272010
Predicting prostate biopsy outcome using a PCA3-based nomogram in a Polish cohort
M Salagierski, P Mulders, JA Schalken
Anticancer research 33 (2), 553-557, 2013
242013
European temporal trends in the use of lymph node dissection in patients with renal cancer
U Capitanio, GD Stewart, A Larcher, I Ouzaid, B Akdogan, M Roscigno, ...
European Journal of Surgical Oncology 43 (11), 2184-2192, 2017
202017
PCA3 and TMPRSS2-ERG: promising biomarkers in prostate cancer diagnosis
M Salagierski, JA Schalken
Cancers 2 (3), 1432-1440, 2010
202010
Do we truly care about the functional outcomes for renal cancer patients? Multidisciplinarity is still far away
U Capitanio, A Larcher, MC Kriegmair, R Bertolo, M Salagierski, R Campi, ...
European urology 75 (2), 349-350, 2019
192019
Diagnostic and prognostic potential of biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in bladder cancers
M Matuszczak, M Salagierski
International Journal of Molecular Sciences 21 (9), 3360, 2020
182020
Chronic kidney disease after partial nephrectomy in patients with preoperative inconspicuous renal function–curiosity or relevant issue?
M Nientiedt, R Bertolo, R Campi, U Capitanio, S Erdem, Ö Kara, T Klatte, ...
Clinical genitourinary cancer 18 (6), e754-e761, 2020
162020
High‐resolution ERG‐expression profiling on GeneChip exon 1.0 ST arrays in primary and castration‐resistant prostate cancer
FP Smit, M Salagierski, S Jannink, JA Schalken
BJU international 111 (5), 836-842, 2013
152013
Management of localized and locally advanced renal tumors. A contemporary review of current treatment options.
S Brookman May, JF Langenhuijsen, A Volpe, A Minervini, S Joniau, ...
Minerva Medica 104, 237-259, 2013
152013
系统目前无法执行此操作,请稍后再试。
文章 1–20